-
301
ANTIBODY-TO-IMAGING PIPELINE TO MONITOR DRUG-TARGET ENGAGEMENT IN BREAST TUMORS
Published 2025-08-01“…However, therapeutic efficacy is often compromised by tumor microenvironment (TME) features, such as dense extracellular matrix and poor vascularization, that limit antibody access and binding. …”
Get full text
Article -
302
Overexpression of the ferroptosis-related gene, NFS1, corresponds to gastric cancer growth and tumor immune infiltration
Published 2025-08-01“…Based on functional enrichment analysis, NFS1 may have a role in ferroptosis and the tumor microenvironment (TME), such as epithelial–mesenchymal transition control, and the stromal and immunologic responses. …”
Get full text
Article -
303
A Needle‐Like H2S‐Releasing and H2O2 Self‐Replenishing Nanoplatform for Enhanced Chemodynamic Tumor Immunotherapy
Published 2025-08-01“…Abstract The tumor microenvironment (TME) significantly restricts chemodynamic therapy (CDT) efficacy through hypoxia and antioxidant defenses. …”
Get full text
Article -
304
Crosstalk between the tumor immune microenvironment and metabolic reprogramming in pancreatic cancer: new frontiers in immunotherapy
Published 2025-04-01“…With the rapid development of sequencing technology, the complex components in the tumor microenvironment (TME) of PC have been gradually revealed. …”
Get full text
Article -
305
Analysis and Functional Significance of TRAP1 in Glioblastoma
Published 2025-07-01“…Exosomal TRAP1 likely participates in intercellular communication, promoting tumor adaptation to stress and the formation of a pro-tumor microenvironment. Conclusion. These findings support the pivotal role of TRAP1 in regulating metabolic status and maintaining aggressive phenotypes in glioblastoma. …”
Get full text
Article -
306
ATG7-deficient fibroblast promotes breast cancer progression via exosome-mediated downregulation of SCARB1
Published 2025-07-01“…Thus, our results indicate that ATG7 expression in fibroblasts plays a vital role in regulating breast cancer tumorigenesis and progression by modifying stromal–epithelial crosstalk and remodeling the tumor microenvironment (TME). These results suggest that ATG7 can function as a tumor suppressor and represent a new candidate for prognosis and targeted therapy.…”
Get full text
Article -
307
Repurposed Antipsychotics as Potential Anticancer Agents: Clozapine Efficacy and Dopaminergic Pathways in Neuroblastoma and Glioblastoma
Published 2025-07-01“…Emerging evidence suggests that dopamine (DA), a neurotransmitter crucial for cognitive and emotional processes, and its receptors may influence tumor growth and the tumor microenvironment. This study aimed to evaluate the potential anticancer effects of repurposed antipsychotic dopamine-targeting drugs (Clozapine, CLZ; Pimozide, PIM; Olanzapine, OLZ; and Risperidone, RIS) and antiemetic drugs (Domperidone, DOM; Droperidol, DRO) on neuroblastoma (SH-SY5Y) and glioblastoma (A172) cell lines, and to assess whether their efficacy is modulated by oxidative stress and DA synthesis. …”
Get full text
Article -
308
Assessing the predictive role of platelet-lymphocyte ratio in EGFR-mutated non-small cell lung cancer patients treated with tyrosine kinase inhibitors: an analysis across TKI gener...
Published 2024-11-01“…The significant changes in peripheral cell counts suggest variable tumor microenvironment changes dependent on the generation of TKI received.…”
Get full text
Article -
309
Mechanistic Foundations of KRAS‐Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment
Published 2025-08-01“…It affects about one‐fifth of cancer cases. The tumor microenvironment (TME) is a multifaceted network of immune cells, metabolites, microbiota, stromal components, and extracellular matrix. …”
Get full text
Article -
310
Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition
Published 2025-10-01“…Ferroptosis has emerged as a promising therapeutic target in cancer therapy, with the tumor microenvironment (TME) playing a pivotal role in regulating ferroptosis. …”
Get full text
Article -
311
An oxidative stress related gene signature predicts prognosis in cholangiocarcinoma
Published 2025-08-01“…Model performance was assessed with Kaplan-Meier survival, ROC curve, PCA, and t-SNE analyses. Tumor microenvironment (TME) features, immune cell infiltration, and chemosensitivity to cisplatin and 5-fluorouracil were also evaluated. …”
Get full text
Article -
312
Viral-Track integrated single-cell RNA-sequencing reveals HBV lymphotropism and immunosuppressive microenvironment in HBV-associated hepatocellular carcinoma
Published 2025-07-01“…Abstract The tumor microenvironment (TME) is a crucial mediator of tumor progression and treatment response. …”
Get full text
Article -
313
MARCO expression on myeloid-derived suppressor cells is essential for their differentiation and immunosuppression
Published 2025-07-01“…Abstract Myeloid-derived suppressor cells (MDSCs) significantly contribute to the immunosuppressive tumor microenvironment (TME), and targeted inhibition of MDSCs is a potential therapeutic strategy against cancer. …”
Get full text
Article -
314
Bibliometric analysis of programmed cell death and immunogenic cell death in hepatocellular carcinoma immunotherapy: global trends and future directions
Published 2025-07-01“…Future studies are expected to focus on immune evasion, tumor microenvironment regulation, novel cell death mechanisms, and personalized immunotherapy. …”
Get full text
Article -
315
Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials
Published 2025-08-01“…ABSTRACT Intra‐tumoral microbiota, which is a potential component of the tumor microenvironment (TME), has been emerging as a key participant and driving factor in cancer. …”
Get full text
Article -
316
Machine Learning‐Enhanced Nanoparticle Design for Precision Cancer Drug Delivery
Published 2025-08-01“…Next, they delve into nano–bio interactions in drug delivery, including NP–protein interactions, blood circulation, NP extravasation into the tumor microenvironment (TME), tumor penetration and distribution, as well as cellular internalization. …”
Get full text
Article -
317
Palmitoylation prevents B7-H4 lysosomal degradation sustaining tumor immune evasion
Published 2025-05-01“…Abstract B7-H4 functions as an immune checkpoint in the tumor microenvironment (TME). However, the post-translational modification (PTM) of B7-H4 and its translational potential in cancer remains incompletely understood. …”
Get full text
Article -
318
Strategies for in situ reprogramming of tumor cells into antigen-presenting cells
Published 2024-11-01“…To address this challenge, researchers have explored strategies to reprogram tumor cells in situ within the tumor microenvironment into immune cells, so as to fully activate anti-tumor immune responses and overcome the limitations of conventional cell therapies that rely on in vitro cell expansion. …”
Get full text
Article -
319
Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
Published 2025-08-01“…Malignant tumors can exacerbate immune disorders through a variety of potential pathways, including pro-inflammatory responses in the tumor microenvironment, cross-immune responses induced by tumor-associated antigens, and the lifting of immunosuppressive states and activation of underlying autoimmune responses after surgery. …”
Get full text
Article -
320
Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy
Published 2025-08-01“…In addition, as a hyaluronan synthase (HAS2/3) inhibitor, 4-MU interfered with the HA-dependent tumor microenvironment and fibrosis process by inhibiting HAS2/3. …”
Get full text
Article